Staphylococcus aureus induces eosinophil cell death mediated by α-hemolysin.

PloS One
Lynne R PrinceMoira K B Whyte

Abstract

Staphylococcus aureus, a major human pathogen, exacerbates allergic disorders, including atopic dermatitis, nasal polyps and asthma, which are characterized by tissue eosinophilia. Eosinophils, via their destructive granule contents, can cause significant tissue damage, resulting in inflammation and further recruitment of inflammatory cells. We hypothesised that the relationship between S. aureus and eosinophils may contribute to disease pathology. We found that supernatants from S. aureus (SH1000 strain) cultures cause rapid and profound eosinophil necrosis, resulting in dramatic cell loss within 2 hours. This is in marked contrast to neutrophil granulocytes where no significant cell death was observed (at equivalent dilutions). Supernatants prepared from a strain deficient in the accessory gene regulator (agr) that produces reduced levels of many important virulence factors, including the abundantly produced α-hemolysin (Hla), failed to induce eosinophil death. The role of Hla in mediating eosinophil death was investigated using both an Hla deficient SH1000-modified strain, which did not induce eosinophil death, and purified Hla, which induced concentration-dependent eosinophil death via both apoptosis and necrosis. We conclu...Continue Reading

References

Jan 1, 1992·Dermatology : International Journal for Clinical and Investigative Dermatology·M K KägiB Wüthrich
Jul 1, 1992·Journal of the American Academy of Dermatology·E J NilssonJ Magnusson
Jan 1, 1991·Methods in Enzymology·R P Novick
Jan 1, 1988·Antonie van Leeuwenhoek·T J FosterA J Bramley
Sep 1, 1988·The American Review of Respiratory Disease·N A FlavahanP M Vanhoutte
May 1, 1974·The British Journal of Dermatology·J J LeydenA M Kligman
Aug 1, 1980·The Journal of Experimental Medicine·W R HendersonS J Klebanoff
May 1, 1995·International Archives of Allergy and Immunology·K G LimP F Weller
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·A ValevaS Bhakdi
Mar 27, 1998·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A NiimiF Kuze
Sep 1, 2000·FEMS Immunology and Medical Microbiology·B E Menzies, I Kourteva
Oct 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·G MenestrinaG Prévost
Feb 2, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lynne R UsherMoira K B Whyte
Mar 20, 2004·International Archives of Allergy and Immunology·Duk-Young MinMyeong Heon Shin
May 18, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Mauricio C A da SilvaEdith Puchelle
Nov 25, 2004·Progress in Biophysics and Molecular Biology·Michael W Parker, Susanne C Feil
Apr 20, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T J GuzikJ Pryjma
Aug 27, 2005·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·K BreuerT Werfel
Feb 16, 2006·Journal of Leukocyte Biology·David H Dockrell, Moira K B Whyte
Nov 15, 2006·Infection and Immunity·Juliane Bubeck WardenburgOlaf Schneewind
Mar 21, 2007·Chemical Immunology and Allergy·C BachertClaudina Perez-Novo
Apr 24, 2007·Veterinary Immunology and Immunopathology·Marianela C SerradellDiana T Masih
Jan 12, 2008·Current Opinion in Allergy and Clinical Immunology·Claus BachertPhilippe Gevaert
Apr 4, 2008·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Simon P HoganMarc E Rothenberg
Jun 21, 2008·Cell Death and Differentiation·K Labbé, M Saleh

❮ Previous
Next ❯

Citations

Feb 12, 2014·American Journal of Respiratory and Critical Care Medicine·Carl Persson, Lena Uller
Apr 16, 2013·Pharmacology & Therapeutics·Ana L AlessandriMauro M Teixeira
May 15, 2013·Trends in Immunology·Barbara GeeringHans-Uwe Simon
Mar 30, 2016·Nature Reviews. Drug Discovery·James N Fullerton, Derek W Gilroy
Oct 2, 2013·Mediators of Inflammation·Ana Rodriguez-FernandezRaul Ortiz de Lejarazu
Jan 8, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C Persson
Nov 12, 2014·Frontiers in Immunology·Lisa A SpencerPeter F Weller
Oct 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wei Yuen Yap, Jung Shan Hwang
Oct 14, 2018·European Journal of Immunology·Susan FarmandBirgitta Henriques-Normark
Dec 18, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C Persson
Jul 10, 2016·Current Allergy and Asthma Reports·Shigeharu UekiPeter F Weller
Nov 15, 2017·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C Auw-Hädrich, T Reinhard
Dec 12, 2018·Frontiers in Immunology·Manali MukherjeeShigeharu Ueki
Feb 9, 2021·Frontiers in Immunology·Dominique Missiakas, Volker Winstel
May 1, 2021·Seminars in Immunopathology·Alessandra GurtnerIsabelle C Arnold
Jul 3, 2021·International Journal of Molecular Sciences·José M Rodrigo-MuñozVictoria Del Pozo

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
flow cytometry
light microscopy

Software Mentioned

GraphPad
FlowJo
PRISM

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.